Ultragenyx Pharmaceutical Inc. RARE 50.72
Health Care · NASDAQ · Data as of 2026-06-22
Ultragenyx Pharmaceutical Inc. (RARE) has delivered +118.6% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #875 of 1993 stocks overall and #93 of 264 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
50.72
Overall Rank
#875 / 1993
Sector Rank
#93 / 264
Revenue CAGR
+118.6%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio